giulia masiero (@giuliamasiero3) 's Twitter Profile
giulia masiero

@giuliamasiero3

MD | Interventional Cardiologist | PhD candidate UNIPD | Past-chair GISE Young @sicigise | @EAPCI Gender and Disparities Commitee | GICI Editorial Board

ID: 1221863271843684356

linkhttp://linkedin.com/in/giulia-masiero-743355138 calendar_today27-01-2020 18:31:29

1,1K Tweet

1,1K Followers

448 Following

Women As One (@womenas1) 's Twitter Profile Photo

Congratulations to our founder, Dr Roxana Mehran, on becoming the American College of Cardiology Vice-President! 🌟 Dr. Mehran is a remarkable advocate for women in cardiology, and we’re proud to have her as a champion empowering women. #WIC #ACC25

Congratulations to our founder, <a href="/Drroxmehran/">Dr Roxana Mehran</a>, on becoming the <a href="/ACCinTouch/">American College of Cardiology</a> Vice-President! 🌟

Dr. Mehran is a remarkable advocate for women in cardiology, and we’re proud to have her as a champion empowering women.

#WIC #ACC25
JACC Journals (@jaccjournals) 's Twitter Profile Photo

What are the outcomes of different mechanical circulatory support strategies in infarct-related cardiogenic shock? Check out this #JACCINT sub-analysis of the ECLS-SHOCK trial jacc.org/doi/10.1016/j.… #CardiogenicShock #cvMI Hans-Josef Feistritzer

What are the outcomes of different mechanical circulatory support strategies in infarct-related cardiogenic shock? Check out this #JACCINT sub-analysis of the ECLS-SHOCK trial jacc.org/doi/10.1016/j.…

#CardiogenicShock #cvMI <a href="/feistritzerH_J/">Hans-Josef Feistritzer</a>
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

I created this short animation to illustrate which drugs are currently under investigation and appear most promising in targeting key steps of the inflammatory cascade—with the hope of demonstrating a reduction in cardiovascular events without incurring a significant cost in

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

In this large, propensity-matched cohort of TAVI patients, only invasively measured postprocedural aortic gradients—not echocardiography-derived gradients—were independently associated with 30-day, 1- and 2-year mortality. These results suggest that invasive assessment may

In this large, propensity-matched cohort of TAVI patients, only invasively measured postprocedural aortic gradients—not echocardiography-derived gradients—were independently associated with 30-day, 1- and 2-year mortality. These results suggest that invasive assessment may
Dr. Gilbert Tang (@gilberttangmd) 's Twitter Profile Photo

Just out #JACCINT JACC Journals with Mateo Marín-Cuartas Syed Zaid, MD et al on CUTTING-EDGE registry showing MV replacement worse than MV repair for failed M-TEER. Unfortunately only 10% of cases are repairable. Let’s aim for <=1+ MR when feasible in both PMR SMR!

MIЯVΛƬ #IC (@mirvatalasnag) 's Twitter Profile Photo

#EuroPCR PCRonline 🫀 EuroIntervention Great meeting to plan for 2025-2026 Plugging in some fantastic #EAPCI documents released today & honored to contribute to them EAPCIPresident 👉 Antithrombotic drugs for ACS in women Valeria Paradies et al eurointervention.pcronline.com/article/antith… 👉

#EuroPCR <a href="/PCRonline/">PCRonline 🫀</a> <a href="/EuroInterventio/">EuroIntervention</a> 

Great meeting to plan for 2025-2026

Plugging in some fantastic #EAPCI documents released today &amp; honored to contribute to them <a href="/EAPCIPresident/">EAPCIPresident</a> 

👉 Antithrombotic drugs for ACS in women <a href="/valeriaparadies/">Valeria Paradies</a> et al

eurointervention.pcronline.com/article/antith…

👉
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

In the field of interventional cardiology, today’s news is that Boston Scientific Corporation has announced the discontinuation of global sales of its ACURATE neo2™ and ACURATE Prime™ aortic valve systems. Over the years, various iterations of this valve have been evaluated in

In the field of interventional cardiology, today’s news is that Boston Scientific Corporation has announced the discontinuation of global sales of its ACURATE neo2™ and ACURATE Prime™ aortic valve systems. Over the years, various iterations of this valve have been evaluated in
Salvatore Brugaletta (@sbrugaletta) 's Twitter Profile Photo

we talk much about new #TAVI devices, but we talk few about a small tip which has improved our practice - at least mine. Use of suture/plug-based strategy for arterial femoral access closure has reduced dramatically vascular complications, if performed together with eco-guided

we talk much about new #TAVI devices, but we talk few about a small tip which has improved our practice - at least mine. Use of suture/plug-based strategy for arterial femoral access closure has reduced dramatically vascular complications, if performed together with eco-guided
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

The next #EAPCIJournalClub episode is coming 🎙️ASK YOUR QUESTION to the #RHEIA #EAPCIJournalClub Team in comments to this post ⬇️ ❗️Top 3 questions will be asked first in the #EAPCIJournalClub❗️ 📕#RHEIA-trial 🗓️30 June 2025 ⏰18:00 CEST 🔗bit.ly/EAPCIJC-RHEIA

The next #EAPCIJournalClub episode is coming

🎙️ASK YOUR QUESTION to the 
#RHEIA #EAPCIJournalClub Team 
in comments to this post  ⬇️
 
❗️Top 3 questions will be asked first in the #EAPCIJournalClub❗️

📕#RHEIA-trial  
🗓️30 June 2025 ⏰18:00 CEST
🔗bit.ly/EAPCIJC-RHEIA
Erik Rafflenbeul (@kardiologiehh) 's Twitter Profile Photo

Register for FREE for the next #EAPCIJournalClub at #ESC365 🔗: bit.ly/EAPCIJC-RHEIA AND ask YOUR question to Prof. Eltchaninoff ⬇️

Register for FREE for the next #EAPCIJournalClub
at #ESC365
🔗: bit.ly/EAPCIJC-RHEIA

AND ask YOUR question to Prof. Eltchaninoff ⬇️
Simone Biscaglia (@simonebiscaglia) 's Twitter Profile Photo

📢📢📢Sei un giovane interventista interessato all'imaging? ❤️‍🔥❤️‍🔥❤️‍🔥Registrati subito su oct2act.it nuovo portale educational dedicato a OCT 1⃣Training 2⃣Morphology journey 3⃣Clinical case 4⃣Research corner 5⃣Games

📢📢📢Sei un giovane interventista interessato all'imaging?
❤️‍🔥❤️‍🔥❤️‍🔥Registrati subito su oct2act.it nuovo portale educational dedicato a OCT
1⃣Training
2⃣Morphology journey
3⃣Clinical case
4⃣Research corner
5⃣Games
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

#EAPCI Online Coaching Programme 🌟 🎉We are launching 3️⃣ different calls 1️⃣ <40 years of age 2️⃣ for the ones returning to clinical practice from sick, maternity or paternity leave; 3️⃣for the ones practicing in countries classified by the World Bank as low and lower-middle

#EAPCI Online Coaching Programme 🌟

🎉We are launching 3️⃣ different calls 

1️⃣ &lt;40 years of age
2️⃣ for the ones returning to clinical practice from sick, maternity or paternity leave;
3️⃣for the ones practicing in countries classified by the World Bank as low and lower-middle
MIЯVΛƬ #IC (@mirvatalasnag) 's Twitter Profile Photo

Golden opportunity & fills unmet needs #EAPCI EAPCIPresident European Society of Cardiology 🔋Were you on parental leave? 🔋Do you come from a low income country? Apply now for a virtual coaching program👉 bit.ly/4l4qn5m Pls spread the word Sarah Birkhoelzer @sarah.theheartdoc Indah Sukmawati, MD Israa Fadhil Yaseen

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Nationwide study (n=791,917) shows #GDMT for HF is underused & underdosed: ✅ 51.2% started on ≥1 GDMT ❌ Most stopped within 3 months 🎯 dose @ 12 months: -BB: 10.5% -ACEi: 7.6% -SGLT2i: 60.2% 🔍 Let’s fix the gap between guidelines & real life jacc.org/doi/10.1016/j.… #JACCAsia

Nationwide study (n=791,917) shows #GDMT for HF is underused &amp; underdosed:
✅ 51.2% started on ≥1 GDMT
❌ Most stopped within 3 months
🎯 dose @ 12 months:
-BB: 10.5%
-ACEi: 7.6%
-SGLT2i: 60.2%
🔍 Let’s fix the gap between guidelines &amp; real life jacc.org/doi/10.1016/j.… #JACCAsia
Dr. Gilbert Tang (@gilberttangmd) 's Twitter Profile Photo

Honored to present on behalf of EXPANDed Investigators at #NYV2025 the 1y echo core lab adjudicated outcomes of #MitraClip M-TEER in SMR pts with COAPT and non-COAPT like criteria: LVEF <20%, LVEDD >70mm, PASP >70mmHg. Similar procedural safety. 1y MR <=1+ 90% both groups!

Honored to present on behalf of EXPANDed Investigators at #NYV2025 the 1y echo core lab adjudicated outcomes of #MitraClip M-TEER in SMR pts with COAPT and non-COAPT like criteria: LVEF &lt;20%, LVEDD &gt;70mm, PASP &gt;70mmHg. 

Similar procedural safety. 1y MR &lt;=1+ 90% both groups!
giulia masiero (@giuliamasiero3) 's Twitter Profile Photo

🎺 #EAPCI online coaching programme! 💻12-month virtual mentoring on #IC EAPCI #member can apply until 23 of july 👉<40 years old 👉 Returning from maternity/paternity or sick leave 👉 Practicing in a low or lower-middle income country 🔎discover more: escardio.org/Sub-specialty-…

🎺 #EAPCI online coaching programme!

💻12-month virtual mentoring on #IC

EAPCI #member can apply until 23 of july
👉&lt;40 years old
👉 Returning from maternity/paternity or sick leave
👉 Practicing in a low or lower-middle income country

🔎discover more:
escardio.org/Sub-specialty-…
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

‼️SAVE THE DATA‼️ The next #EAPCI Webinar is coming: 🎯Timely treatment of asymptomatic patients with #AorticStenosis ➡️ Insights from the EARLY TAVR trial ⬅️ 🗓️30 July 2025 ⏰17 - 18 CEST Register for 🆓 at #ESC365: 🔗: bit.ly/EAPCI_EarlyTAVR #PreWebinarSurvey next Post⬇️

‼️SAVE THE DATA‼️
The next #EAPCI Webinar is coming:
🎯Timely treatment of asymptomatic patients with #AorticStenosis
➡️ Insights from the EARLY TAVR trial ⬅️

🗓️30 July 2025
⏰17 - 18 CEST

Register for 🆓 at #ESC365: 
🔗: bit.ly/EAPCI_EarlyTAVR

#PreWebinarSurvey next Post⬇️